Emergence of ADCs as the “hot, new technology”
The recent acquisition of ImmunoGen by AbbVie, which followed the earlier acquisition of Seagen by Pfizer, has brought renewed attention to antibody-drug conjugates (ADCs), highlighting the
Innovation as Strategy: Enabling life sciences of the future
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
The many trends reshaping clinical trials: An interview with...
Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
How doctors are interacting with content in 10 data trends
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
Patient Centricity to Integration: Enhancing Cancer Outcomes
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
9th Microbiome Movement Drug Development Summit
The Home of Accelerating Microbial-Based Drug Development
The PM Society – Giving Back
The PM Society is a not-for-profit organisation with 40 years of Giving Back.